Author:
Ball P,Mandell L,Patou G,Dankner W,Tillotson G
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone;Cormican;Antimicrob Agents Chemother,1997
2. Anti-streptococcal activity of SB−265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines;Johnson;Diagn Microbiol Infect Dis,1999
3. Comparative tolerability of the newer fluoroquinolone antibacterials;Ball;Drug Saf,1999
4. Temafloxacin syndrome: review of 95 cases;Blum;Clin Infect Dis,1994
5. EMEA (European Agency for the Evaluation of Medicinal Products). Public statement on Trovan/Trovan IV/Turvel/Turvel IV (trovafloxacin/alatrofloxacin). Recommendation to suspend the marketing authorisation in the European Union. EMEA/18046/99; 15 June 1999.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献